Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Farmers Insurance
McKinsey
Chubb
US Army

Generated: May 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,861,411

« Back to Dashboard

Summary for Patent: 6,861,411
Title: Method of treating eye infections with azithromycin
Abstract:The invention features methods and compositions for treating ocular infections. The method comprises topically administering to an eye of an animal in need of such treatment an ocular infection-treating amount of azithromycin.
Inventor(s): Ahmed; Imran (East Lyme, CT)
Assignee: Pfizer, Inc. (New York, NY)
Application Number:09/200,119
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,861,411
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,861,411
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 6,861,411

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,861,411

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 271390 ➤ Try a Free Trial
Brazil 9805318 ➤ Try a Free Trial
Canada 2254682 ➤ Try a Free Trial
Germany 69825128 ➤ Try a Free Trial
Denmark 0925789 ➤ Try a Free Trial
European Patent Office 0925789 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Teva
Cipla
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.